Even the most effective health products cannot save lives or improve health if they do not reach the people who want and need them.
That is why markets—the systems, structures and institutions that facilitate the buying and selling of health products—matter.
When markets function well and are healthy, then well‐designed, quality-assured, and affordable health products are consistently available.
Welcome to Markets Matter, a collection of thought leadership pieces from a diverse group of nongovernmental organizations, the private sector, and donors.
Through the below roundup we hope to elevate the role well-functioning markets play in supporting access to health products. We invite you to read these expert blogs and follow #MarketsMatter to join in a lively online conversation with us.
Healthy markets: essential to improving health and saving lives
By Ray Cummings, director of Market Dynamics at PATH
Markets matter: successes in global health market dynamics
By Susan Nazzaro, senior program officer at the Bill & Melinda Gates Foundation
Making vaccine markets work: 15 years of lessons learned
By Melissa Malhame, head of Market Shaping at Gavi, the Vaccine Alliance
Leveraging markets for global health
By Wendy Taylor, director, and Amy Lin, senior market access advisor, lead market shaping at USAID’s Center for Accelerating Innovation and Impact (CII)
Implementing total market approaches for family planning in Uganda
By Joyce Tamale, managing director of the Uganda Health Marketing Group
Keeping all options open: how the private sector helped Senegal address its market challenges for family planning and bring back choice to women
By Dr. Priya Agrawal, executive director at Merck for Mothers
In Africa, markets matter for a healthy society
By Craig Williams, general manager for West Africa, GlaxoSmithKline (GSK)
Incentives and innovative financing mechanisms matter in addressing market failures
By Erin Will Morton, director of the Global Health Technologies Coalition
New tool helps bridge manufacturers to potential markets
By John Skibiak, director of the Reproductive Health Supplies Coalition
Quality matters: cheap uterotonics—bargain or burden?
By Fiona Theunissen, project officer at Access to Maternal Health and Dr. Hans Vemer, CEO of the Concept Foundation
Access to innovation: In reach for all?
By Dr. David Kaslow, vice president of product development at PATH and leader of the PATH Center for Vaccine Innovation and Access